Cancer Research · 2004 · 81 citations · 33 references
MedicineCell BiologyOncologyApoptosisMolecular OncologyNeoplasiaKidney CancerRenal Cell CarcinomaTargeted Cancer TherapyTumor Suppressor GenesCell Growth RegulationMalignant ProgressionParathyroid Hormone BiologyParathyroid Hormone-related Protein SignalingPost-transcriptional RegulationVon Hippel-lindau DiseaseVon Hippel-lindau Syndrome
Clear cell renal carcinoma (CCRC) is responsible for 2% of cancer-related deaths worldwide and is resistant to virtually all therapies, indicating the importance of a search for new therapeutic targets. Parathyroid hormone-related protein (PTHrP) is a polyprotein derived from normal and malignant cells that regulates cell growth. In the current study, we show that blocking PTHrP with antibodies or antagonizing the common parathyroid hormone (PTH)/PTHrP receptor, the PTH1 receptor, dramatically blunts the expansion of human CCRC in vitro by promoting cell death. Importantly, in nude mice, anti-PTHrP antibodies induced complete regression of 70% of the implanted tumors by inducing cell death. In addition, we demonstrate that the von Hippel-Lindau tumor suppressor protein, which functions as a gatekeeper for CCRC, negatively regulates PTHrP expression at the post-transcriptional level. These studies indicate that PTHrP is an essential growth factor for CCRC and is a novel target for the von Hippel-Lindau tumor suppressor protein. Taken together, these results strongly suggest that targeting the PTHrP/PTH1 receptor system may provide a new avenue for the treatment of this aggressive cancer in humans.
33
THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA
Allan J. Pantuck, Amnon Zisman, Arie S. Belldegrun · The Journal of Urology · 2001 · 842 citations
Medicine, Cancer Biology, Oncology +10
Tumour suppression by the human von Hippel-Lindau gene product
Othon Iliopoulos, Adam S. Kibel, Steven G. Gray et al. · Nature Medicine · 1995 · 716 citations
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
Robert J. Motzer, Paul Russo · The Journal of Urology · 2000 · 606 citations
Medicine, Oncology, Pharmacotherapy +15
Kim M. Lonergan, Othon Iliopoulos, Michael Ohh et al. · Molecular and Cellular Biology · 1998 · 381 citations